SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E. Graphs who wrote (598)2/22/1998 7:08:00 AM
From: X. Fang  Read Replies (2) of 834
 
Technically speaking, It's unlikely that TXB will be hold back by $7 1/2. On the long chart, the initial resist is at 8 1/4 to 8 3/4 level. The stock has been preparing for this break out since October, 1997. We might see some consolidation once it reaches 8 1/2. But it should be a very short one before it test $10 since FDA approval is only 4-5 month away. I believe that FAD's approval will push this one above $15, at lease on intra-day base. The old all-time intra-day high was 7 1/4, it just does make any sense that we stop at 7 1/2 after almost a year.

Take a look of this weekly chart and MACD indicator, you will agree with me,
bigcharts.com

Sean
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext